<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01575665</url>
  </required_header>
  <id_info>
    <org_study_id>8313-86</org_study_id>
    <nct_id>NCT01575665</nct_id>
  </id_info>
  <brief_title>Normalizing CO2 in Chronic Hyperventilation by a Novel Breathing Mask: A Pilot Study</brief_title>
  <acronym>HVMASKE</acronym>
  <official_title>CO2 Rebreathing by a Partial Rebreathing Mask as a Treatment of Chronic Idiopathic Hyperventilation - a Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>BalancAir</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Aarhus</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: Chronic Idiopathic Hyperventilation (CIH) is a form of dysfunctional breathing
      which has proven hard to treat effectively. The investigators hypothesised that by
      periodically inducing normocapnia over several weeks, it would be possible to raise the
      normal resting level/set point of CO2 and achieve a reduction of symptoms.

      Methods: Six CIH patients were treated two hours a day for four weeks with a novel breathing
      mask. The mask was used to induce normocapnia in these chronically hypocapnic patients.

      Capillary blood gases (PcCO2, pH, Standard Base Excess (SBE) etc.) were measured at baseline
      and once each week at least three hours after mask use, as well as spirometric values, breath
      holding tolerance and hyperventilation symptoms as per the Nijmegen Questionnaire (NQ),.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">June 2011</completion_date>
  <primary_completion_date type="Actual">June 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood gas and acid/base status</measure>
    <time_frame>Once every week in the treatment period of four weeks</time_frame>
    <description>pH, PCO2, PO2, Standard Base Excess</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hyperventilation symptoms</measure>
    <time_frame>once a week</time_frame>
    <description>Nijmegen Questionnaire</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Breath Hold Tolerance</measure>
    <time_frame>once a week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Spirometric values</measure>
    <time_frame>once a week</time_frame>
    <description>FEV1, FVC</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">6</enrollment>
  <condition>Hyperventilation</condition>
  <condition>Chronic Idiopathic Hyperventilation</condition>
  <condition>Dysfunctional Breathing</condition>
  <condition>Respiratory Alkalosis</condition>
  <arm_group>
    <arm_group_label>Partial Rebreathing Mask</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>A novel membrane breathing mask which facilitates a partial rebreathing of expired gas (thereby raising systemic CO2), while allowing a diffusion of oxygen from the atmosphere to the user, through the membranes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Partial Rebreathing Mask</intervention_name>
    <description>Inducing normal CO2 for two hours a day for four weeks</description>
    <arm_group_label>Partial Rebreathing Mask</arm_group_label>
    <other_name>CDA mask</other_name>
    <other_name>Balancair Mask</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Chronic idiopathic hyperventilation, i.e.:

          -  PCO2 level below 4.7 kPa AND

          -  SBE value more negative than -1.0

        Exclusion Criteria:

          -  Oxygen saturation of 95% or lower at rest
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronald Dahl</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Aarhus University Hospital</name>
      <address>
        <city>Aarhus</city>
        <zip>DK-8000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 10, 2012</study_first_submitted>
  <study_first_submitted_qc>April 10, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 11, 2012</study_first_posted>
  <last_update_submitted>May 18, 2016</last_update_submitted>
  <last_update_submitted_qc>May 18, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 19, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Hyperventilation</keyword>
  <keyword>Chronic Idiopathic Hyperventilation</keyword>
  <keyword>Dysfunctional Breathing</keyword>
  <keyword>Respiratory Alkalosis</keyword>
  <keyword>Respiratory Acidosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Aspiration</mesh_term>
    <mesh_term>Hyperventilation</mesh_term>
    <mesh_term>Alkalosis</mesh_term>
    <mesh_term>Alkalosis, Respiratory</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

